Purchase by Srinivas Akkaraju / Samsara BioCapital, L.P. / Samsara BioCapital GP, LLC / Samsara Opportunity Fund, L.P. / Samsara Opportunity Fund GP, LLC
Kalaris Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $4.90
-52% since the alert
$10.24 → $4.90
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS